Efficacy and Safety of Docetaxel Plus Oxaliplatin and Capecitabine in the First Line Treatment of Advanced Gastric Adenocarcinoma

Objective. To evaluate the efficacy and safety of docetaxel plus oxaliplatin and capecitabine (DOX) in the first line treatment of advanced gastric adenocarcinoma. Methods. A total of 37 patients were enrolled into this study, and they received DOX regimen (docetaxel 75 mg/m(2) and oxaliplatin 130 m...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Liu, Ying, Ye, Zhengbao, Xi, Wenqi, Ma, Tao, Shi, Min, Yang, Liu, Zhu, Zhenggang, Zhang, Jun
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2013
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3787590/
https://ncbi.nlm.nih.gov/pubmed/24151630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/971096
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires